Terahertz Imaging of Excised Oral Cancer at Frozen Temperature
Overview
Affiliations
The feasibility of terahertz (THz) imaging at frozen temperature for the clinical application of oral cancer detection was investigated by analyzing seven oral tissues resected from four patients. The size, shape, and internal position of the oral cancers were mapped by THz radiation in the frequency range of 0.2-1.2 THz at -20 °C and 20 °C, and compared with those identified in the histological examination. THz imaging of frozen tissue was found to offer greater sensitivity in distinguishing cancerous areas from surrounding tissue and a larger THz-frequency spectral difference between the oral cancer and normal mucosa than room-temperature THz imaging. A cancerous tumor hidden inside tissue was also detected using this method by observing the THz temporal domain waveform. The histological analysis showed that these findings resulted from cell structure deformations involving the invasion of oral tumor and neoplastic transformations of mucous cells. Therefore, a cytological approach using THz radiation at a frozen temperature might be applied to detect oral cancer.
Ding X, Hernandez-Serrano A, Young J, Pickwell-MacPherson E Biomed Opt Express. 2024; 15(9):5180-5198.
PMID: 39296403 PMC: 11407259. DOI: 10.1364/BOE.527731.
High-sensitivity THz-ATR imaging of cerebral ischemia in a rat model.
Li H, Wang Y, Wang Z, Mu N, Chen T, Xu D Biomed Opt Express. 2024; 15(6):3743-3754.
PMID: 38867801 PMC: 11166429. DOI: 10.1364/BOE.524466.
Terahertz technology and its applications in head and neck diseases.
Shi S, Yuan S, Zhou J, Jiang P iScience. 2023; 26(7):107060.
PMID: 37534152 PMC: 10391736. DOI: 10.1016/j.isci.2023.107060.
Qi X, Bertling K, Stark M, Taimre T, Kao Y, Lim Y Biomed Opt Express. 2023; 14(4):1393-1410.
PMID: 37078035 PMC: 10110320. DOI: 10.1364/BOE.480615.
Quantitative evaluation of transdermal drug delivery patches on human skin with THz-TDS.
Ding X, Costa G, Hernandez-Serrano A, Stantchev R, Nurumbetov G, Haddleton D Biomed Opt Express. 2023; 14(3):1146-1158.
PMID: 36950242 PMC: 10026588. DOI: 10.1364/BOE.473097.